HAURAKI PHO
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact
  • Home
  • About us
    • Our People
  • Services We Offer
    • HPHO Practices
    • After Hours Services
    • Breast and Cervical Screening Support
    • Diabetes Management
    • Heart Check
    • Ngā Kaitiaki Manawanui Whai Ora
    • Outreach Immunisation Service
    • Primary Options
    • Patient Portal
    • Primary Mental Health Services
    • Shared Electronic Health Record
  • News & Support
    • Education and Training
    • Coronavirus Updates >
      • COVID-19 Vaccine Updates
    • Join the Team!
  • Hauraki Locality
  • Contact

Amgevita (biosimilar adalimumab) funded from 1 March 2022

23/2/2022

 
In November 2021 we announced the decision to widen access to adalimumab and award Principal Supply to Amgevita, a citrate-free biosimilar adalimumab. Amgevita will be listed in the Pharmaceutical Schedule from 1 March 2022.
 
What does this change mean
From 1 March 2022, most patients currently using Humira will need to transition to Amgevita.
 
There are some key actions that healthcare professionals can take to support this change.
 
  • Be aware that on 1 March 2022, all people currently using adalimumab will be automatically issued with an initial Special Authority number for Amgevita. Their Humira Special Authority will remain current.
  • Ensure you prescribe adalimumab by brand (either Amgevita or Humira).
  • Identify patients using adalimumab and discuss the continuation of their treatment with Amgevita when their Humira Special Authority is due for renewal, or before 1 October 2022.
  • Go to amgevita.co.nz for resources to support you and your patients with this change.
  • Go to the Pharmac website for information about the changes to funding criteria for Humira.​
continued...
More information
You can find more information about this change, and what it means for you, on the Pharmac website.
 
Resources are available to support you and your patients with this change:
He Ako Hiringa: Biological Medicines Resource Hub
He Ako Hiringa: Transition to adalimumab biosimilar
 
More resources will be released in the coming weeks. We will continue to update the Pharmac website with links to resources to support this change as they become available.

Please share this information
We want to make sure everyone who needs to know about these changes is aware of them. Please share this information with your colleagues. 
 
We want to extend our thanks to you and your colleagues for supporting people with this change.

Click here for the mailer


Ngā mihi nui,
Chief Medical Officer | Tumu Whakarae Haumanu
Pharmac

Govt ensures extra support for Māori and Pacific Omicron response

22/2/2022

 
Extra support is being made available to Māori and Pacific communities as they continue to face the impact of the current Omicron outbreak.This extra support is in addition to the Care in the Community boost the Government announced last week to help all families who need to self-isolate, as well as the social service organisations and community providers working hard to support them.
Omicron is likely to disproportionately affect Māori and Pasifika communities, and the Government is committed to making sure vulnerable whanau received the support and care they deserve.

Click here to read the full update


HiNZ- Nursing Informatics & Midwifery Newsletter February 2022

22/2/2022

 
23 February 2022
Got some news to share with the group? Email sector@hinz.org.nz

Hi Lisa,Message from the chair of HiNZ-NMIWelcome to 2022!
We are resilient in healthcare, but I have had a sense of ‘oh dear, here we go again….’ However we are very used to just ‘rolling with it’ and ‘going with the flow’. What other choice do we have?

Healthcare is a rollercoaster at the moment and there are many ebbs and flows on that ride. The use of technology in healthcare continues to make its presence felt within this pandemic (my Dad has even succumbed to getting a smart phone). If we take a look from a more positive point of view, that is certainly something that we can take away from the experiences we have all had over the last two years. When this is all over (note I specifically said ‘when’ not ‘if’) we will have advanced our healthcare services and achieved greater connectivity and technologically competent practitioners.

Click here to read the full Newsletter


Government provides stability for whānau self-isolating

18/2/2022

 
he Government is standing up additional support to help people and whānau who have to self-isolate access the services they need as Omicron cases start to ramp up and more New Zealanders are affected by the virus.
With Omicron cases increasing it is important whānau have the support they need to self-isolate and stop the spread of the virus.
In recent weeks we have seen an over 60 percent increase in people with no existing MSD relationship needing support, so it is timely for us to be increasing the welfare support provided through the Care in Community approach.

Click here for more information



CLINICAL UPDATE - Pathlab Waikato Automation Failure - February 2022

15/2/2022

 
Good afternoon, on behalf of Dr Stephen du Toit, Pathologist and John Woodford, Lead of Specialty Biochemistry as attached. 

We are grateful if you could please ensure all relevant persons in your organisation are advised.
​
 Click here for the full update

Updates: Toolkit, booster campaign and handy tools to check out

11/2/2022

 
It has been a very busy start to the year with vaccinations for 5-11 year olds, boosters, red traffic lights and Omicron in the community. Great work is going on around the country, thanks to all our wonderful vaccinators.

We have quite a few updates for you to support this work:
  • February toolkit is out, we have an update to our vaccine comparison table
  • 8 week interval for 5-11 year olds and variation 3-8 weeks, checking age
  • Booster February, booster intervals 3 calendar months, CIR
  • Medical exemptions
Take care out there,

Click here for your February Toolkit


Ngā mihi nui
Immunisation Advisory Centre team 

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    October 2022
    August 2022
    July 2022
    March 2022
    February 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020

    Categories

    All

    RSS Feed

THAMES
106 Sealey Street, Thames 3500
phone 07-868-9686
Send us a message
HAMILTON
​18 Karewa Place ,Pukete
​Hamilton 3200

phone 07-868-9686
Send us a message
Picture
Copyright © Hauraki Primary Health Organisation  |  2020